Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FNQ5V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,757
Award facts
- Contract value 100% obligated
- $14,757.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,757.38 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of December 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime agreement valued through December 2026 that supports global pharmaceutical supply to military healthcare programs.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and military medical supply chains. The company's extensive federal contract portfolio demonstrates its capability to deliver specialty medications, brand-name and generic pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic areas. Enbrel, an immunosuppressant biologic used to treat rheumatoid arthritis and other autoimmune conditions, is procured through this delivery order to support military and federal healthcare beneficiaries. The DLA's strategy of maintaining multiple pharmaceutical prime vendors ensures supply chain resilience and competition for medical commodity delivery to support worldwide military operations and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FNQ5V?
SPE2DR26FNQ5V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FNQ5V worth?
The government has obligated $14,757 on SPE2DR26FNQ5V.
Is contract SPE2DR26FNQ5V an order under another contract?
Yes. SPE2DR26FNQ5V is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNQ5V competed?
The extent of competition for SPE2DR26FNQ5V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award